Stock INAB IN8BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart IN8bio, Inc.

Equities

INAB

US45674E1091

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.01 USD 0.00% Intraday chart for IN8bio, Inc. +1.00% -26.81%
May. 09 IN8bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 In8bio, Inc. Doses First Patient in Phase 2 Clinical Trial of Inb-400 in Newly Diagnosed Glioblastoma CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
IN8BIO, INC.
Bio Therapeutic Drugs
0.00%+1.00%-26.81%-57.02% - 44.46M
Bearish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. INAB Stock
  4. Charts IN8bio, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW